Universal-Beteiligungs- und Servicegesellschaft
NTLA icon

Universal-Beteiligungs- und Servicegesellschaft’s Intellia Therapeutics NTLA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.39M Buy
186,781
+88,184
+89% +$1.12M ﹤0.01% 1182
2025
Q4 		$893K Sell
98,597
-14,841
-13% -$204K ﹤0.01% 1528
2025
Q3 		$1.96M Buy
113,438
+48,438
+75% +$597K ﹤0.01% 1305
2025
Q2 		$610K Hold
65,000
– – ﹤0.01% 1633
2025
Q1 		$462K Buy
+65,000
New +$657K ﹤0.01% 1669

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's NTLA Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Intellia Therapeutics (NTLA) stake by 89% in Q1 2026, buying an estimated $1.12M and bringing the position to 186,781 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in NTLA in Q1 2025 and has held it in 5 quarters since. 302 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 186,781 shares of Intellia Therapeutics worth $2.39M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 88,184 Intellia Therapeutics shares in Q1 2026, an estimated $1.12M.
  • Intellia Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1182 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Intellia Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 302 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.